ELITE PHARMACEUTICALS INC (21) | Business Finance (6)

Browse by Subcategory

Recent Contracts

Series J Preferred Stock and Series J Common Stock Purchase Warrant anti-dilution waiver (Filed With SEC on August 14, 2020)
August 1, 2013, Asset Purchase Agreement between the Company and Mikah Pharma LLC (Filed With SEC on July 31, 2020)
Registration Rights Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 9, 2020)
Purchase Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 9, 2020)
Asset Purchase Agreement dated November 13, 2019 by and between the Company and Nostrum Laboratories Inc (Filed With SEC on February 10, 2020)
Asset Purchase Agreement executed January 16, 2020 by and between the Company and Nostrum Laboratories Inc (Filed With SEC on February 10, 2020)